Inhibition of alanine and aspartate aminotransferases by alpha-oxoderivatives of the branched-chain amino acids.
D000410:Alanine Transaminase / Q000037:antagonists & inhibitors*; D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D001219:Aspartate Aminotransferases / Q000037:antagonists & inhibitors*; D001393:Azoles / Q000494:pharmacology; D001665:Binding Sites; D001921:Brain / Q000201:enzymology; D002208:Caproates / Q000494:pharmacology; D006801:Humans; D007651:Keto Acids / Q000494:pharmacology*; D007700:Kinetics; D007930:Leucine / Q000494:pharmacology; D008099:Liver / Q000201:enzymology; D008375:Maple Syrup Urine Disease / Q000378:metabolism; D009928:Organ Specificity; D011485:Protein Binding; D011733:Pyridoxamine; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D000637:Transaminases / Q000037:antagonists & inhibitors; D014631:Valerates / Q000494:pharmacology
D000596:Amino Acids; D001393:Azoles; D002208:Caproates; D007651:Keto Acids; D014631:Valerates; D011733:Pyridoxamine; D000637:Transaminases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D007930:Leucine